Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Madrigal Pharmaceuticals (MDGL) Debt Ratio (2022 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Debt Ratio for 10 consecutive years, with 0.27 as the latest value for Q4 2025.

  • Quarterly Debt Ratio rose 139.21% to 0.27 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.27 through Dec 2025, up 139.21% year-over-year, with the annual reading at 0.27 for FY2025, 139.21% up from the prior year.
  • Debt Ratio for Q4 2025 was 0.27 at Madrigal Pharmaceuticals, up from 0.25 in the prior quarter.
  • The five-year high for Debt Ratio was 0.48 in Q3 2023, with the low at 0.11 in Q2 2024.
  • Average Debt Ratio over 4 years is 0.21, with a median of 0.18 recorded in 2023.
  • The sharpest move saw Debt Ratio plummeted 77.37% in 2024, then skyrocketed 139.21% in 2025.
  • Over 4 years, Debt Ratio stood at 0.14 in 2022, then soared by 32.62% to 0.18 in 2023, then crashed by 37.43% to 0.11 in 2024, then skyrocketed by 139.21% to 0.27 in 2025.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.27, 0.25, and 0.12 for Q4 2025, Q3 2025, and Q2 2025 respectively.